NasdaqGM - Delayed Quote USD
Actuate Therapeutics, Inc. Common stock (ACTU)
10.35
+0.45
+(4.55%)
At close: 4:00:02 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
Total Assets
9,318.45
2,995.57
20,483.06
Total Liabilities Net Minority Interest
9,214.26
102,622.08
95,788.49
Total Equity Gross Minority Interest
104.19
-99,626.51
-75,305.43
Total Capitalization
104.19
-99,626.51
-75,305.43
Common Stock Equity
104.19
-99,626.51
-75,305.43
Net Tangible Assets
104.19
-99,626.51
-75,305.43
Working Capital
405.40
-3,925.03
16,138.07
Invested Capital
104.19
-99,626.51
-75,305.43
Tangible Book Value
104.19
-99,626.51
-75,305.43
Share Issued
19,531.64
19,111.64
19,111.64
Ordinary Shares Number
19,531.64
19,111.64
19,111.64
12/31/2022 - 8/13/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RNTX Rein Therapeutics Inc.
1.7600
+1.15%
RNXT RenovoRx, Inc.
1.0600
+1.92%
CGTX Cognition Therapeutics, Inc.
0.3011
-8.76%
CUE Cue Biopharma, Inc.
0.7797
+1.52%
COYA Coya Therapeutics, Inc.
6.05
-2.58%
ELTX Elicio Therapeutics, Inc.
5.49
-1.44%
IDYA IDEAYA Biosciences, Inc.
17.42
-4.18%
APS.TO Aptose Biosciences Inc.
2.2100
-0.45%
NBTX Nanobiotix S.A.
3.4100
+1.49%
LTRN Lantern Pharma Inc.
3.9800
+3.11%